COMMUNIQUÉS West-GlobeNewswire
-
International Gastroenterology Expert Working Group Publishes Consensus Framework for Improved Classification of Gastric Function in Patients with Chronic Stomach Conditions
08/07/2026 -
MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
08/07/2026 -
Weight Watchers and FlavCity Announce Collaboration Focused on Strength, Nutrition, and Community
08/07/2026 -
Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication
08/07/2026 -
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
08/07/2026 -
GumiTide Official Announces 2026 In The USA & Canada New Advanced Formula Gumitide Gummies For Weight Loss in Markets
08/07/2026 -
Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection
08/07/2026 -
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
08/07/2026 -
Philips introduces Alturion ultrasound system with AI-powered workflows for high-volume clinical environments
08/07/2026 -
UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer
08/07/2026 -
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/07/2026 -
Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026
08/07/2026 -
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months
08/07/2026 -
Polomar Health Services Strengthens Board Leadership to Support Standalone Growth Strategy
08/07/2026 -
Nordic Ranked No. 1 Overall in Black Book’s 2026 Healthcare IT Consulting and Advisory Services Report
08/07/2026 -
Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026
08/07/2026 -
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
08/07/2026 -
As America Celebrates its 250th Birthday, Becoming Independent Marks 59 Years of Helping People Live on Their Own Terms
08/07/2026 -
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
08/07/2026
Pages